Cargando…
Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923909/ https://www.ncbi.nlm.nih.gov/pubmed/33681439 http://dx.doi.org/10.1016/j.jdcr.2021.02.018 |
| _version_ | 1783658985314844672 |
|---|---|
| author | Munavalli, Girish Gilly Knutsen-Larson, Siri Lupo, Mary P. Geronemus, Roy G. |
| author_facet | Munavalli, Girish Gilly Knutsen-Larson, Siri Lupo, Mary P. Geronemus, Roy G. |
| author_sort | Munavalli, Girish Gilly |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7923909 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79239092021-03-03 Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation Munavalli, Girish Gilly Knutsen-Larson, Siri Lupo, Mary P. Geronemus, Roy G. JAAD Case Rep Case Series Elsevier 2021-03-02 /pmc/articles/PMC7923909/ /pubmed/33681439 http://dx.doi.org/10.1016/j.jdcr.2021.02.018 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Series Munavalli, Girish Gilly Knutsen-Larson, Siri Lupo, Mary P. Geronemus, Roy G. Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation |
| title | Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation |
| title_full | Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation |
| title_fullStr | Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation |
| title_full_unstemmed | Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation |
| title_short | Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation |
| title_sort | oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following covid-19 vaccination-a model for inhibition of angiotensin ii–induced cutaneous inflammation |
| topic | Case Series |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923909/ https://www.ncbi.nlm.nih.gov/pubmed/33681439 http://dx.doi.org/10.1016/j.jdcr.2021.02.018 |
| work_keys_str_mv | AT munavalligirishgilly oralangiotensinconvertingenzymeinhibitorsfortreatmentofdelayedinflammatoryreactiontodermalhyaluronicacidfillersfollowingcovid19vaccinationamodelforinhibitionofangiotensiniiinducedcutaneousinflammation AT knutsenlarsonsiri oralangiotensinconvertingenzymeinhibitorsfortreatmentofdelayedinflammatoryreactiontodermalhyaluronicacidfillersfollowingcovid19vaccinationamodelforinhibitionofangiotensiniiinducedcutaneousinflammation AT lupomaryp oralangiotensinconvertingenzymeinhibitorsfortreatmentofdelayedinflammatoryreactiontodermalhyaluronicacidfillersfollowingcovid19vaccinationamodelforinhibitionofangiotensiniiinducedcutaneousinflammation AT geronemusroyg oralangiotensinconvertingenzymeinhibitorsfortreatmentofdelayedinflammatoryreactiontodermalhyaluronicacidfillersfollowingcovid19vaccinationamodelforinhibitionofangiotensiniiinducedcutaneousinflammation |